Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Appiah-Ankam, J.
Right arrow Articles by Hunter, J. M
Right arrow Search for Related Content
PubMed
Right arrow Articles by Appiah-Ankam, J.
Right arrow Articles by Hunter, J. M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Continuing Education in Anaesthesia Critical Care and Pain | Volume 4 Number 1 | 2004
© The Board of Management and Trustees of the British Journal of Anaesthesia 2004

Pharmacology of neuromuscular blocking drugs

Jonas Appiah-Ankam, MB ChB FRCA, Honorary Lecturer
University Department of Anaesthesia, University Clinical Department, Duncan Building, Daulby Street, Liverpool

Jennifer M Hunter, MB ChB PhD FRCA, Professor
University Department of Anaesthesia, University Clinical Department, Duncan Building, Daulby Street, Liverpool L69 3GA
Tel: 0151 7064008, Fax: 0151 7065884, E-mail: jennie{at}liv.ac.uk (for correspondence)

Neuromuscular blocking drugs (NMBDs) have become an established part of anaesthetic practice since Griffith and Johnson in Montreal first described the use of curare to facilitate muscle relaxation in a healthy man undergoing an appendicectomy in 1942.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.